However, considering the limitations of using HbA1c in cases of low Hb (anemia) or accelerated red blood cell turnover (due to chronic kidney disease), MG, due to its close relationship with insulin resistance, must be considered as a potential diagnostic and prognostic marker, not limited to DM [83]. This evidence concerns the gene GSTM1 and anemia.